Studies show GLP-1 receptor agonists reduce cardiovascular events by 2030% in high-risk patients, which insurers and HSA plan administrators recognize as legitimate medical treatment
Some users have also reported thyroid tumors and other significant health issues
Ill just continue to fight in the trenches against this at times
Its levels decrease with age, affecting both health and appearance, and contributing to diseases like cancer, diabetes, and neurological disorders
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
